Skip to main content

KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001348911

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

13F holders, Q2 2025

Institutional positions in KalVista Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
140
+13 vs. Q1 2025
Shares held
54.4M
−474.5K (−0.9%) vs. Q1 2025
Total value
$615.5M
−$18.1M (−2.9%) vs. Q1 2025
New holders
30
55 more added
Sold out
17
32 more reduced

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 140 institutions
Q1 2021: 117 institutionsQ2 2021: 110 institutionsQ3 2021: 105 institutionsQ4 2021: 97 institutionsQ1 2022: 89 institutionsQ2 2022: 91 institutionsQ3 2022: 94 institutionsQ4 2022: 91 institutionsQ1 2023: 88 institutionsQ2 2023: 94 institutionsQ3 2023: 101 institutionsQ4 2023: 93 institutionsQ1 2024: 129 institutionsQ2 2024: 119 institutionsQ3 2024: 122 institutionsQ4 2024: 130 institutionsQ1 2025: 128 institutionsQ2 2025: 140 institutionsQ3 2025: 145 institutionsQ4 2025: 162 institutionsQ1 2026: 184 institutionsQ2 2026: 1 institution
Value heldQ2 2025: $615.5M
Q1 2021: $605.1MQ2 2021: $582.7MQ3 2021: $408.2MQ4 2021: $314.6MQ1 2022: $363.9MQ2 2022: $238.7MQ3 2022: $372.0MQ4 2022: $236.2MQ1 2023: $265.0MQ2 2023: $310.1MQ3 2023: $349.2MQ4 2023: $453.0MQ1 2024: $557.2MQ2 2024: $568.2MQ3 2024: $561.0MQ4 2024: $467.4MQ1 2025: $633.7MQ2 2025: $615.5MQ3 2025: $714.0MQ4 2025: $1.08BQ1 2026: $1.39BQ2 2026: $189
Institutions holding KALV and their total value by quarter
QuarterHoldersValue
Q2 20261$189
Q1 2026184$1.39B
Q4 2025162$1.08B
Q3 2025145$714.0M
Q2 2025140$615.5M
Q1 2025128$633.7M
Q4 2024130$467.4M
Q3 2024122$561.0M
Q2 2024119$568.2M
Q1 2024129$557.2M
Q4 202393$453.0M
Q3 2023101$349.2M
Q2 202394$310.1M
Q1 202388$265.0M
Q4 202291$236.2M
Q3 202294$372.0M
Q2 202291$238.7M
Q1 202289$363.9M
Q4 202197$314.6M
Q3 2021105$408.2M
Q2 2021110$582.7M
Q1 2021117$605.1M

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q1 2025.

Institutions holding KALV in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Goldman Sachs Group Inc134,398$1.52M0.00%−205,538−60.5%Reduced
Schonfeld Strategic Advisors LLC145,282$1.64M0.01%−436,464−75.0%Reduced
Boothbay Fund Management, LLC148,927$1.68M0.05%+148,927New
Nan Fung Trinity (HK) Ltd154,522$1.75M0.21%+154,522New
Hennion & Walsh Asset Management, Inc.155,961$1.76M0.07%+44,855+40.4%Added
Rosalind Advisors, Inc.157,725$1.78M0.86%−146,139−48.1%Reduced
Barclays PLC168,923$1.91M0.00%+113,696+205.9%Added
Dimensional Fund Advisors LP173,209$1.96M0.00%−472,784−73.2%Reduced
F/M Investments LLC182,262$2.06M0.07%+132,165+263.8%Added
Ikarian Capital, LLC198,528$2.24M0.74%+198,528New
First Turn Management, LLC214,138$2.42M0.45%+214,138New
Morgan Stanley239,629$2.71M0.00%+15,840+7.1%Added
UBS Group AG272,861$3.08M0.00%−234,842−46.3%Reduced
Panagora Asset Management Inc292,593$3.31M0.01%+220,697+307.0%Added
Susquehanna International Group, LLP294,198$3.33M0.01%+242,030+463.9%Added
Citigroup Inc299,194$3.38M0.00%+150,967+101.8%Added
Great Point Partners LLC323,170$3.65M2.38%−691,197−68.1%Reduced
Millennium Management LLC340,629$3.85M0.00%+142,424+71.9%Added
Northern Trust Corp352,152$3.98M0.00%−35,410−9.1%Reduced
Bank of America Corp366,966$4.15M0.00%+58,719+19.0%Added
StemPoint Capital LP386,790$4.37M1.41%−470.0%Reduced
Schroder Investment Management Group554,958$6.27M0.01%−313,053−36.1%Reduced
DAFNA Capital Management LLC581,757$6.58M1.82%−170,602−22.7%Reduced
Parkman Healthcare Partners LLC679,063$7.68M0.89%−74,689−9.9%Reduced
Emerald Mutual Fund Advisers Trust768,972$8.69M0.53%+160,759+26.4%Added
Geode Capital Management, LLC941,212$10.6M0.00%+25,971+2.8%Added
Ameriprise Financial Inc945,125$10.7M0.00%+905,053+2,258.6%Added
Emerald Advisers, LLC1,038,049$11.7M0.43%+139,859+15.6%Added
Octagon Capital Advisors LP1,273,333$14.4M3.16%−96,667−7.1%Reduced
State Street Corp1,349,539$15.3M0.00%+255,896+23.4%Added
Silverarc Capital Management, LLC1,832,171$20.7M4.24%+133,187+7.8%Added
Woodline Partners LP1,920,664$21.7M0.11%+303,195+18.7%Added
Vanguard Group Inc2,412,399$27.3M0.00%+113,801+5.0%Added
BlackRock, Inc.3,129,494$35.4M0.00%−22,241−0.7%Reduced
Capital World Investors3,177,587$35.9M0.01%00.0%Unchanged
Vestal Point Capital, LP4,675,000$52.9M2.78%−76,292−1.6%Reduced
Frazier Life Sciences Management, L.P.4,887,867$55.3M2.21%00.0%Unchanged
Tang Capital Management LLC4,941,798$55.9M2.82%00.0%Unchanged
Suvretta Capital Management, LLC4,955,000$56.0M2.11%+41,988+0.9%Added
VR Adviser, LLC6,728,985$76.1M5.70%+25,000+0.4%Added
Jefferies Financial Group Inc.0$00.00%−375,000−100.0%Sold out
Adage Capital Partners GP, L.L.C.0$00.00%−276,000−100.0%Sold out
Walleye Capital LLC0$00.00%−249,161−100.0%Sold out
Nan Fung Group Holdings Ltd0$00.00%−154,522−100.0%Sold out
Diadema Partners LP0$00.00%−135,509−100.0%Sold out
Persistent Asset Partners Ltd0$00.00%−34,098−100.0%Sold out
HighVista Strategies LLC0$00.00%−33,305−100.0%Sold out
PDT Partners, LLC0$00.00%−23,654−100.0%Sold out
Corebridge Financial, Inc.0$00.00%−19,094−100.0%Sold out
Ieq Capital, LLC0$00.00%−10,915−100.0%Sold out
ProShare Advisors LLC0$00.00%−10,666−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−337−100.0%Sold out
Smartleaf Asset Management LLC0$00.00%−279−100.0%Sold out
Caitong International Asset Management Co., Ltd0$00.00%−157−100.0%Sold out
Coldstream Capital Management Inc0$00.00%−69−100.0%Sold out
Stephens Consulting, LLC0$00.00%−30−100.0%Sold out
Capital Performance Advisors LLP0$00.00%−3,845−100.0%Sold out
Lindbrook Capital, LLC––––Not filed